Summary

U.S. Imaging Services Market Growth & Trends

The U.S. imaging services market size is expected to reach USD 192.1 billion by 2028, expanding at a CAGR of 7.3% from 2021 to 2028, according to a new study conducted by Grand View Research, Inc. Growing prevalence of various conditions, such as cancer and cardiac disorders, is expected to drive the market. Imaging services involve different imaging modalities, such as X-ray, CT scans, nuclear medicine scans, MRI scans, and ultrasound. Each modality includes its own associated advantages of diagnosing a wide range of healthcare conditions accurately.

Adoption of imaging services in U.S. is increasing gradually to enhance early diagnosis of the disease, which, in turn, improves its treatment options. Moreover, growing adoption of non-invasive and cost-efficient procedures is expected to contribute to market growth. Medical imaging services consume less time in comparison to other invasive procedures and thus helps in reducing hospital stay and cost associated with it. Various technologies are being developed to enhance medical imaging devices by improving the image quality captured by them. These fine and sharp images help in diagnosing the disease at an early stage, thereby improving its treatment outcomes.

The number of outpatient settings in U.S. is increasing rapidly and installation of advanced imaging devices in these settings is on the rise. As per the Organization for Economic Co-operation and Development (OECD), in 2018, 20.6 per 1,000,000 inhabitants MRI units were installed in ambulatory care providers. Moreover, growing number of CT scans in U.S. is expected to propel the overall market growth. As per Statista, in 2017, 255.7 per 1,000 inhabitants CT scans were performed in U.S. Additionally, low cost of the CT scans in comparison to MRI is expected to drive its adoption.

Major challenges in this market include high cost of certain modalities, such as MRI, and side effects associated with each imaging modality. MRI scans are mainly preferred in diagnosing various conditions as they help in proper tissue differentiation. However, the average cost of the procedure in U.S. is USD 1,430, which is high in comparison to other imaging modalities, thus hindering the overall market growth.

U.S. imaging Services Market Report Highlights

• Based on modality, X-rays held the largest share in 2019 mainly due to increasing adoption of non-invasive procedures for diagnosis at an affordable cost

• Nuclear medicine scans are expected to witness significant growth during the forecast period as the radiation dosage used in the procedure is low, which, in turn, reduces the chance of infection

• MRI scans are expected to grow at a significant rate during the forecast period as they help in better tissue differentiation in comparison to other modalities, such as CT and X-ray

• By end use, hospitals held the largest share in the U.S. market owing to growing prevalence of cardiac diseases and cancer and installation of advanced imaging modalities in the hospitals

• Diagnostic imaging centers are expected to witness the fastest growth due to growing preference of patient pool for these centers to reduce hospital-associated cost and long wait time

• The others segment, which includes outpatient settings developed by hospitals, is also expected to grow at a significant rate as these settings provide few imaging services, such as MRI and CT, at low cost in comparison to other settings.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End-use outlook
2.3. Competitive Insights
Chapter 3. U.S. Imaging Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of cancer and cardiac disorders
3.4.1.2. Growing number of outpatient settings with imaging services
3.4.1.3. Growing awareness of medical imaging
3.4.2. Market restraint analysis
3.4.2.1. High cost of MRI services
3.4.2.2. Side effects of imaging modalities
3.4.3. Industry challenges
3.5. U.S. Imaging Services Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Modality Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. X-rays
4.1.2. CT scans
4.1.3. Nuclear medicine scans
4.1.4. MRI scans
4.1.5. Ultrasound
4.2. Modality Market Share, 2020 & 2028
4.3. Segment Dashboard
4.4. U.S. Imaging Services Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. X-rays
4.5.1.1. Market estimates and forecast 2016 - 2028 (Revenue in USD Billion, Volume, Units)
4.5.2. CT scans
4.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion, Volume, Units)
4.5.3. Nuclear medicine scans
4.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion, Volume, Units)
4.5.4. MRI scans
4.5.4.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion, Volume, Units)
4.5.5. Ultrasound
4.5.5.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion, Volume, Units)
Chapter 5. End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic imaging centers
5.1.3. Others
5.2. End-use Market Share, 2020 & 2028
5.3. Segment Dashboard
5.4. U.S. Imaging Services Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Hospitals
5.5.1.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion)
5.5.2. Diagnostic imaging centers
5.5.2.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion)
5.5.3. Others
5.5.3.1. Market estimates and forecast, 2016 - 2028 (Revenue in USD Billion)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.2.2. Market Leaders
6.2.3. Emerging Players
6.3. Public Companies
6.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.3.2. Company Market Share/Ranking, by region
6.3.3. Competitive Dashboard Analysis
6.3.3.1. Market Differentiators
6.3.3.2. Synergy Analysis: Major Deals and Strategic Alliances
6.4. Private Companies
6.4.1. List of key emerging companies/technology disruptors/innovators
6.4.2. Funding Outlook
6.4.3. Regional Network Map
6.4.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.5. Supplier Ranking
6.6. Key company profiled
6.6.1. Radnet, Inc.
6.6.1.1. Company overview
6.6.1.2. Financial performance
6.6.1.3. Product benchmarking
6.6.1.4. Strategic initiatives
6.6.2. Sonic Healthcare
6.6.2.1. Company overview
6.6.2.2. Financial performance
6.6.2.3. Product benchmarking
6.6.2.4. Strategic initiatives
6.6.3. Dignity Health
6.6.3.1. Company overview
6.6.3.2. Financial performance
6.6.3.3. Product benchmarking
6.6.3.4. Strategic initiatives
6.6.4. Novant Health
6.6.4.1. Company overview
6.6.4.2. Financial performance
6.6.4.3. Product benchmarking
6.6.4.4. Strategic initiatives
6.6.5. Alliance Medical
6.6.5.1. Company overview
6.6.5.2. Financial performance
6.6.5.3. Product benchmarking
6.6.5.4. Strategic initiatives
6.6.6. Inhealth Group
6.6.6.1. Company overview
6.6.6.2. Financial performance
6.6.6.3. Product benchmarking
6.6.6.4. Strategic initiatives
6.6.7. Medica Group
6.6.7.1. Company overview
6.6.7.2. Financial performance
6.6.7.3. Product benchmarking
6.6.7.4. Strategic initiatives
6.6.8. Global Diagnostics
6.6.8.1. Company overview
6.6.8.2. Financial performance
6.6.8.3. Product benchmarking
6.6.8.4. Strategic initiatives
6.6.9. Healthcare Imaging Services Pty Ltd.
6.6.9.1. Company overview
6.6.9.2. Financial performance
6.6.9.3. Product benchmarking
6.6.9.4. Strategic initiatives
6.6.10. Concord Medical Services Holdings Limited
6.6.10.1. Company overview
6.6.10.2. Financial performance
6.6.10.3. Product benchmarking
6.6.10.4. Strategic initiatives
6.6.11. Center for Diagnostic Imaging, Inc.
6.6.11.1. Company overview
6.6.11.2. Financial performance
6.6.11.3. Product benchmarking
6.6.11.4. Strategic initiatives
6.6.12. Unilabs
6.6.12.1. Company overview
6.6.12.2. Financial performance
6.6.12.3. Product benchmarking
6.6.12.4. Strategic initiatives
6.6.13. Healius Limited
6.6.13.1. Company overview
6.6.13.2. Financial performance
6.6.13.3. Product benchmarking
6.6.13.4. Strategic initiatives
6.6.14. Simonmed Imaging
6.6.14.1. Company overview
6.6.14.2. Financial performance
6.6.14.3. Product benchmarking
6.6.14.4. Strategic initiatives
6.6.15. Alliance HealthCare Services, Inc.
6.6.15.1. Company overview
6.6.15.2. Financial performance
6.6.15.3. Product benchmarking
6.6.15.4. Strategic initiatives